生物医药

病毒性肿瘤的防治
肿瘤的发病机制及早期诊断

1. Li Wang*, Jintao Li*, Na Zhang*, Xiaofei Zhang, Yang Xia, Binbin Chai, Chunlang Gao, Shengcheng Mao, Yuan Ji, Wang Sheng, Xiaodong Han. Investigations of EGFR configurations on tumor cell surface by high resolution electron microscopy. Biochemical and Biophysical Research Communications, 2020, 532:179-184
2. Yang Xia, Jintao Li*, Shuying Li, Sara Khodahemmati, Maliha Ghaffar, Su Chen, Wang Sheng. Identification of pathways and genes in the process of E6/E7-induced carcinogenesis of esophageal epithelial cells. J Med Virol. 2020, 1–7.
3. Jun Hao, Shuying Li, Jintao Li*, Zhu Jiang, Maliha Ghaffar, Minglian Wang, Runqing Jia, Su Chen, Yangjunqi Wang, Yi Zeng. Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues. Experimental and therapeutic medicine. 2019. 18(3): 1816-1822
4. Maliha Ghaffar, Sara Khodahemmati, Jintao Li*, Muhammad Shahzad, Minglian Wang, Yangjunqi Wang, Changshuo Li, Su Chen, Yi Zeng, Long Noncoding RNA LINC01234 Regulates Proliferation, Invasion and Apoptosis in Esophageal Cancer. Journal of cancer, 2018; 9(22:): 4242-4249
5. Maliha Ghaffar, Jintao Li*, Lei Zhang, Sara Khodahemmati, Minglian Wang, Yangjunqi Wang, Lijiao Zhao, Runqing Jia, Su Chen, and Yi Zeng. Water carcinogenicity and prevalence of HPV infection in Esophageal cancer patients in Huaihe river basin, China. Gastroenterology Research and Practice. 2018, 4:1-8
6. Hongwei Liu, Jintao Li*, Yubai Zhou, Qin Hu, Yi Zeng, and Mohammadzad Mehryar Mohammadreza, Papillomavirus as a Favorable Prognostic Factor in a Subset oHef ad and Neck Squamous Cell Carcinomas: A Meta-Analysis. J Med Virol. 2017,89(4):710-725
7. Shuying Li, Zhanjun Liu, Jianghong Yan, Shangbo Sun, Xiaoli Hou, Dianqing Liu, Ke Zhang, and Jintao Li*, Integration sites of human papillomavirus 18 in esophageal cancer samples, ONCOLOGY LETTERS, 2018, DOI: 10.3892/ol.2018.8191

1. 科技部重大专项子课题，2006BAI19B03、淮河流域水污染与肿瘤相关性评估研究。
2. 北京市教委基金科技一般项目，KM201910005004，基于非编码RNA参与的MAGEA6的激活调控机制研究。
3. 北京市自然科学基金面上项目，5162003，黑色素瘤抗原A6基因参与的HPV18致癌新机制研究。
4. 国家科技重大专项，25015001201201，多载体保护性抗体基因疫苗序贯和重复应用的研究。